Navigating The Complex Oncology Landscape
By Gerhard Du Toit, Global Oncology Head, IQVIA Biotech, and Murray Aitken, Executive Director, IQVIA Institute For Human Data Science
In recent years, there have been notable advancements in oncology research and development, offering renewed hope to patients around the world through innovative treatment options. Much of this progress can be attributed to emerging biotech companies, which play a significant role, contributing as much as 70% to the overall research and development pipeline.
Referencing insights from the Global Oncology Trends 2023 report by the IQVIA Institute for Human Data Science, you can gain valuable knowledge about how global oncology trends are impacting sponsors and how to enhance your clinical trial strategy in the following key areas:
- Early-Stage Oncology Trial Design and Strategy
- Designing Platform Trials
- Enhancing Diversity Planning in Clinical Trial Protocols
Access the full report below to gain essential insights to help optimize your approach to these critical aspects of oncology research.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.